Dr. Jonathan Ethan Tannebaum, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 251 N 4th St, Oakland, MD 21550 Phone: 301-533-4000 Fax: 301-895-8751 |
Dr. Charles A Walch, M.D., F.A.C.S. Surgery Medicare: Accepting Medicare Assignments Practice Location: 255 North 4th Street, Suite 2, Oakland, MD 21550 Phone: 301-334-8282 Fax: 301-334-8468 |
Marjorie Sue Fridkin, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 255 North 4th Street, Suite 2, Oakland, MD 21550 Phone: 301-334-8282 Fax: 301-334-8468 |
Dr. Charles William Fedde, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 410 Sam Snead Cir, Oakland, MD 21550 Phone: 301-334-2050 Fax: 301-334-1792 |
News Archive
Genzyme Corp. has announced that it has filed with the U.S. Food and Drug Administration (FDA) for approval of Synvisc-One, the single treatment of Synvisc (hylan G-F 20) that provides up to six months of pain relief from osteoarthritis (OA) of the knee.
The drug crizotinib (trade name: Xalkori) has been available since 2012 for patients with advanced non-small cell lung cancer (bronchial carcinoma) who have a high activity of the enzyme anaplastic lymphoma kinase (ALK) and have already received another treatment. In November 2015, the approval was extended to first-line treatment.
The incidence of auto-immune diseases like type 1 diabetes and allergies has risen dramatically in developed countries over the past fifty years. The reasons for this trend are not fully understood but a theory known as the 'hygiene hypothesis' links it to a rise in hygiene standards.
Grandma has Alzheimer's disease - should you sign her up for a new research study, even if she doesn't really understand what it entails?
› Verified 7 days ago